A PEGylated Nanocarrier for Oral Delivery of Immunomodulator Thymopentin

MM Liu - 2023 - researchspace.auckland.ac.nz
The oral delivery of drugs is the most popular route of administration for patients. However,
thymopentin (TP5) is only available in the market in forms for parenteral administration as an …

Cellular Uptake and Transport Mechanism Investigations of PEGylated Niosomes for Improving the Oral Delivery of Thymopentin

M Liu, D Svirskis, T Proft, J Loh, Y Huang, J Wen - Pharmaceutics, 2024 - mdpi.com
Background: Although its immunomodulatory properties make thymopentin (TP5) appealing,
its rapid metabolism and inactivation in the digestive system pose significant challenges for …

Exploring ex vivo peptideolysis of thymopentin and lipid-based nanocarriers towards oral formulations

M Liu, D Svirskis, T Proft, J Loh, S Chen, D Kang… - International journal of …, 2022 - Elsevier
The oral delivery of medicines is the most popular route of administration for patients.
However, thymopentin (TP5) is only available in the market in forms for parenteral …

Thymopentin nanoparticles engineered with high loading efficiency, improved pharmacokinetic properties, and enhanced immunostimulating effect using soybean …

C Wu, M Zhang, Z Zhang, KW Wan… - Molecular …, 2014 - ACS Publications
Formulation of protein and peptide drugs with sustained release properties is crucial to
enhance their therapeutic effect and minimize administration frequency. In this study …

Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin

YS Yin, DW Chen, MX Qiao, Z Lu, HY Hu - Journal of controlled release, 2006 - Elsevier
The purpose of this study was to design and evaluate lectin-conjugated PLGA nanoparticles
for oral delivery of thymopentin. Thymopentin loaded PLGA nanoparticles (TP5–NPs) were …

Carrier-free delivery of thymopentin-regulated injectable nanogels via an enhanced cancer immunity cycle against melanoma metastasis

N Ding, K He, H Tian, L Li, Q Li, S Lu, K Ding, J Liu… - Materials Today Bio, 2023 - Elsevier
Abstract Thymopentin (TP5), a clinically used immunomodulatory pentapeptide, can
efficiently promote thymocyte differentiation and influence mature T-cell function, thus …

Box–Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles

X Jin, A Huang, Q Ping, F Cao… - Die Pharmazie-An …, 2011 - ingentaconnect.com
This study was done to prepare thymopentin (TP5)-loaded poly (butyl cyanoacrylate)
nanoparticles (TP5-PBCA-NPs) and evaluate thier efficacy for oral delivery. TP5-PBCA-NPs …

Research on thymopentin loaded oralN-trimethyl chitosan nanoparticles

X Yuan, Z Zhang, Q Song, Q He - Archives of pharmacal research, 2006 - Springer
Peptides, although high efficacy and specificity in their physiological function, usually have
low therapeutical activities due to their poor bioavailability when administrated orally …

Thymopentin-loaded pH-sensitive chitosan nanoparticles for oral administration: preparation, characterization, and pharmacodynamics

AP Zheng, JC Wang, WL Lu, X Zhang… - … of nanoscience and …, 2006 - ingentaconnect.com
Thymopentin, a potent immunomodulating drug, was incorporated into pH-sensitive chitosan
nanoparticles prepared by ionic gelation of chitosan with tripolyphosphate anions and then …

Preformulation studies of thymopentin: analytical method development, physicochemical properties, kinetic degradation investigations and formulation perspective

M Liu, D Svirskis, T Proft, JMS Loh… - Drug development and …, 2021 - Taylor & Francis
Thymopentin (TP5) is a synthetic pentapeptide with immunomodulatory properties. Given
the previously described poor absorption of TP5, preformulation data is required to support …